A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma

BACKGROUND: To date only a handful of drugs are available for the treatment of melanoma. Among them vemurafenib, a Braf(V600E) specific inhibitor, showed promising results in terms of response rate and increase in median survival time. However, its effectiveness is limited by development of resistan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bhandaru, Madhuri, Ardekani, Gholamreza Safaee, Zhang, Guohong, Martinka, Magdalena, McElwee, Kevin J, Li, Gang, Rotte, Anand
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4051389/
https://ncbi.nlm.nih.gov/pubmed/24893747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-398
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak